These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17846109)

  • 1. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline.
    Miller SL; Fenstermacher E; Bates J; Blacker D; Sperling RA; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):630-5. PubMed ID: 17846109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD.
    Dickerson BC; Salat DH; Greve DN; Chua EF; Rand-Giovannetti E; Rentz DM; Bertram L; Mullin K; Tanzi RE; Blacker D; Albert MS; Sperling RA
    Neurology; 2005 Aug; 65(3):404-11. PubMed ID: 16087905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
    Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
    Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal atrophy confounds template-based functional MR imaging measures of hippocampal activation in patients with mild cognitive impairment.
    Sandstrom CK; Krishnan S; Slavin MJ; Tran TT; Doraiswamy PM; Petrella JR
    AJNR Am J Neuroradiol; 2006 Sep; 27(8):1622-7. PubMed ID: 16971599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semantic memory activation in amnestic mild cognitive impairment.
    Woodard JL; Seidenberg M; Nielson KA; Antuono P; Guidotti L; Durgerian S; Zhang Q; Lancaster M; Hantke N; Butts A; Rao SM
    Brain; 2009 Aug; 132(Pt 8):2068-78. PubMed ID: 19515831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial temporal lobe function and structure in mild cognitive impairment.
    Dickerson BC; Salat DH; Bates JF; Atiya M; Killiany RJ; Greve DN; Dale AM; Stern CE; Blacker D; Albert MS; Sperling RA
    Ann Neurol; 2004 Jul; 56(1):27-35. PubMed ID: 15236399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
    van de Pol LA; van der Flier WM; Korf ES; Fox NC; Barkhof F; Scheltens P
    Neurology; 2007 Oct; 69(15):1491-7. PubMed ID: 17923611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.
    Atri A; O'Brien JL; Sreenivasan A; Rastegar S; Salisbury S; DeLuca AN; O'Keefe KM; LaViolette PS; Rentz DM; Locascio JJ; Sperling RA
    Arch Neurol; 2011 May; 68(5):599-606. PubMed ID: 21555634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal volumetric MRI change and rate of cognitive decline.
    Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical responses to a graded working memory challenge predict functional decline in mild cognitive impairment.
    Kochan NA; Breakspear M; Valenzuela M; Slavin MJ; Brodaty H; Wen W; Trollor JN; Turner A; Crawford JD; Sachdev PS
    Biol Psychiatry; 2011 Jul; 70(2):123-30. PubMed ID: 21546002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the time to clinically worsening in mild cognitive impairment patients and its utility in clinical trial design by modeling a longitudinal clinical dementia rating sum of boxes from the ADNI database.
    Ito K; Hutmacher MM
    J Alzheimers Dis; 2014; 40(4):967-79. PubMed ID: 24531162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cognitive decline in healthy older adults using fMRI.
    Woodard JL; Seidenberg M; Nielson KA; Smith JC; Antuono P; Durgerian S; Guidotti L; Zhang Q; Butts A; Hantke N; Lancaster M; Rao SM
    J Alzheimers Dis; 2010; 21(3):871-85. PubMed ID: 20634590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
    den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
    Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline.
    O'Brien JL; O'Keefe KM; LaViolette PS; DeLuca AN; Blacker D; Dickerson BC; Sperling RA
    Neurology; 2010 Jun; 74(24):1969-76. PubMed ID: 20463288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
    Bakkour A; Morris JC; Dickerson BC
    Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
    Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.